UNSPSC 51241712: Sodium chloride/sorbic acid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241712 Sodium chloride/sorbic acid is a Commodity code that in practice encompasses generic pharmaceuticals and over-the-counter products supplied through state and local cooperative purchasing frameworks. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary recent issuer under this code, soliciting manufacturers to supply comprehensive pharmaceutical inventories across participating state and local government facilities. State and local health agencies, hospitals, correctional systems, and social service departments use this code to procure shelf-stable generic drugs, topical preparations, and OTC remedies for patient care and institutional use. Vendors must meet FDA compliance standards, maintain current Good Manufacturing Practices certification, and demonstrate Drug Supply Chain Security Act compliance. The code reflects procurement of finished pharmaceuticals rather than raw chemical ingredients, despite the nominal scope of the UNSPSC category name.

The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts effective July 1, 2026, with participating jurisdictions spanning Minnesota and Oregon. The procurement emphasizes price competitiveness at 75 percent of evaluation weight, requiring vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) and to accept a 3 percent administrative fee on all contract purchases. Vendors must maintain commercial general liability insurance of $5,000,000 per occurrence and contractual relationships with at least two of the three authorized wholesalers with active chargeback systems. MMCAP reserves the right to make sole, dual, or multi-awards based on therapeutic considerations and member-specific needs; no specific set-aside designations were identified in the available solicitation materials.